Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis

Details for Australian Patent Application No. 2009272814 (hide)

Owner Novartis AG

Inventors Manley, Paul W.; Buchdunger, Elisabeth

Agent Davies Collison Cave

Pub. Number AU-A-2009272814

PCT Pub. Number WO2010/007034

Priority 08160366.4 14.07.08 EP

Filing date 14 July 2009

Wipo publication date 21 January 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/007034 Priority application(s): WO2010/007034

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272815-Plants having enhanced yield-related traits and a method for making the same

2009272810-Treatment monitoring